LPCN - Lipocine Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue428.031---
Cost of Revenue4,648.6829,278.9696,126.92910,030.337
Gross Profit-4,220.651-9,278.969-6,126.929-10,030.337
Operating Expenses
Research Development1,816.0261,725.3121,949.1242,549.908
Selling General and Administrative5,289.14210,213.69510,382.1465,801.823
Non Recurring----
Others----
Total Operating Expenses11,753.8521,217.97618,458.19918,382.068
Operating Income or Loss-11,325.819-21,217.976-18,458.199-18,382.068
Income from Continuing Operations
Total Other Income/Expenses Net-333.503235.816-512.557173.89
Earnings Before Interest and Taxes-11,325.819-21,217.976-18,458.199-18,382.068
Interest Expense-793-793-793-793
Income Before Tax-11,659.322-20,982.16-18,970.756-18,208.178
Income Tax Expense0.70.70.7520.2
Minority Interest----
Net Income From Continuing Ops-11,660.022-20,982.86-18,971.508-18,208.378
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,660.022-20,982.86-18,971.508-18,208.378
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,660.022-20,982.86-18,971.508-18,208.378